Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
New England Journal of Medicine · 02.10.2025 · 393 (13) · 1279-1291
DOI: 10.1056/nejmoa2507227 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 02.10.2025. Verfasst von Brian A Bergmark und 18 weiteren Autor:innen. Beteiligte Einrichtung: TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston. Hauptthemen laut MEDLINE: Apolipoprotein C-III, Hypertriglyceridemia, Oligonucleotides, Oligonucleotides, Antisense. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: NIDDK NIH HHS, Ionis Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston.
- Harvard Medical School, Boston.
- Ionis Pharmaceuticals, Carlsbad, CA.
- MOVE Academic Research Organization, Hospital Moinhos de Vento, Moinhos de Vento College of Health Sciences, Porto Alegre, Brazil.
- Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.
- VA Connecticut Healthcare System, West Haven, CT.
ORCID-Profile: Brian A Bergmark
Förderung
- NIDDK NIH HHS
- Ionis Pharmaceuticals
Zitieren
APA
Bergmark, B. A., Marston, N. A., Prohaska, T. A., Alexander, V. J., Zimerman, A., Moura, F. A., Kang, Y. M., Weinland, J., Murphy, S. A., Goodrich, E. L., Zhang, S., Li, D., Banach, M., Stroes, E., Lu, M. T., Tsimikas, S., Giugliano, R. P., Sabatine, M. S., & Essence–TIMI 73b Investigators (2025). Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. New England Journal of Medicine, 393(13), 1279-1291. https://doi.org/10.1056/nejmoa2507227
Vancouver
Bergmark BA, Marston NA, Prohaska TA, Alexander VJ, Zimerman A, Moura FA, et al. Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. New England Journal of Medicine. 2025;393(13):1279-1291. doi:10.1056/nejmoa2507227
BibTeX
@article{Bergmark2025,
author = {Bergmark, Brian A and Marston, Nicholas A and Prohaska, Thomas A and Alexander, Veronica J and Zimerman, Andre and Moura, Filipe A and Kang, Yu Mi and Weinland, Julia and Murphy, Sabina A and Goodrich, Erica L and Zhang, Shuanglu and Li, Dan and Banach, Maciej and Stroes, Erik and Lu, Michael T and Tsimikas, Sotirios and Giugliano, Robert P and Sabatine, Marc S and Essence–TIMI 73b Investigators, Essence–TIMI 73b Investigators},
title = {Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {13},
pages = {1279--1291},
doi = {10.1056/nejmoa2507227}
}
EUVIMED